Irissh Blood Transfusion Service has announced on 13 Apr 2022 that is accepting bids for the following project: Ireland-Dublin: Sterilisation, disinfection and hygiene devices.
The tender will take place in Ireland and will cover the Pharmaceutical & Medical industry.
The total value of the project is estimated at 600000, ex VAT and you can apply until 01 Jan 1970.
After the deadline, Global Database will announce the contract award for Ireland-Dublin: Sterilisation, disinfection and hygiene devices. In order to stay up-to-date with this tender and also to receive daily notifications about similar projects, you can subscribe to our newsletter for free.
Bellow you can find more information about the tender description and the bidding procedure.
Location: Ireland
Irissh Blood Transfusion Service
Pharmaceutical & Medical
Accepting bids
13 Apr 2022
Not available
600000
Voluntary ex ante transparency notice
Supplies
Section I: Contracting authority/entity
Section II: Object
Arm Cleansing System
The IBTS previously participated in a collaborative procurement with the NHSBT, NIBTS, WBS and the SNBTS for this product (OJEU) only one suitable product (Chloroprep)was identified for use within Blood Establishments. A new tender was held within the UK and only one submission was received (Chloroprep was the product offered. Due to Brexit the IBTS can only be supplied from with Europe under a Product Licence. This means the approved supplier for this product is Iskus Health limited in Ireland
The IBTS previously participated in a collaborative procurement with the NHSBT, NIBTS, WBS and the SNBTS for this product and the contract was extended. However due to issues from Brexit (Product Licensing v Product Authorisation), the supplier at the time (Insight Healthcare) was not able to provide the product to the IBTS. Best practice in skin disinfection is defined in Evidence Based Practice in Infection Control Guidelines Version 3 (EPIC3) commissioned by the United Kingdom (UK) Department of Health (DoH) which recommended that a solution of chlorhexidine and alcohol should be used. The only product which is a) sterile in individual applicator form; b) contains the required 2% chlorhexidine gluconate / 70% isopropyl alcohol formulation. This product is provided by Iskus Health Limited in Ireland under a Product Licence issued by the HPRA
Option to extend by two 12 months
Section IV: Procedure
The IBTS had previously tendered with the UK for Arm Cleansing Products through OJEU, only one suitable product was identified. The UK held an Open competition for this requirement in 2021, only one tender was received from the market. Due to Brexit and the requirement for Product License (PL) the successful tenderer could not provide the product to the IBTS. However the same product with the PL could be provided by Iskus Heath Limited. This is the only suitable product for use in Blood Establishments. On that basis a Negotiated Procedure was out into place
The NHSBT published the notice and awarded the contract
Only one response was received
A Voluntary ex Ante Transparency (VEAT) Notice will be made on OJEU
Fair, Open, Transparent, Competition is evidenced
Value for Money can be demonstrated.
Section V: Award of contract/concession
Section VI: Complementary information
Receive Daily Tenders and Grants notifications
Subscribe nowFeatured tenders
Enter your contact details
One of our experts will be in touch shortly to arrange a convenient time to book a Demo Presentation.
Home pageEnter your contact details
One of our experts will be in touch shortly to arrange a convenient time to book a Demo Presentation.
Home page